1 |
Saraux N, Bruna L, Ebrahimi SN, Karimou S, Christen P, Cuendet M. Antiproliferative activity of compounds isolated from the root bark of Lannea acida in multiple myeloma cell lines. Phytochemistry 2023;209:113641. [PMID: 36907430 DOI: 10.1016/j.phytochem.2023.113641] [Reference Citation Analysis]
|
2 |
Liu Y, Li H, Luo Z, Yu Y, Yang J, Zhang M, Law BYK, Huang Z, Li W. Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe(2+) pathways. Br J Pharmacol 2023;180:701-20. [PMID: 36368726 DOI: 10.1111/bph.15986] [Reference Citation Analysis]
|
3 |
Aziz A, Wang H, Wang Y, Li Z, Yang C, Ma Z, Xiao X, Liu J. Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma. Cancers (Basel) 2023;15. [PMID: 36900317 DOI: 10.3390/cancers15051526] [Reference Citation Analysis]
|
4 |
Ambrosio FA, Costa G, Gallo Cantafio ME, Torcasio R, Trapasso F, Alcaro S, Viglietto G, Amodio N. Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma. Molecules 2023;28. [PMID: 36771100 DOI: 10.3390/molecules28031438] [Reference Citation Analysis]
|
5 |
Pandya SK, Pandya A, Larsen A, Gowin K. A Review of The Synergistic Effects of Curcumin with Proteasome Inhibitors in Multiple Myeloma Preclinical Models. Integr Cancer Ther 2023;22:15347354231159322. [PMID: 36879488 DOI: 10.1177/15347354231159322] [Reference Citation Analysis]
|
6 |
Jöhrer K, Galarza Pérez M, Kircher B, Çiçek SS. Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives from Dracocephalum moldavica and Their In Vitro Effects on Multiple Myeloma and Acute Myeloid Leukemia. Int J Mol Sci 2022;23. [PMID: 36430695 DOI: 10.3390/ijms232214219] [Reference Citation Analysis]
|
7 |
Ding K, Jiang W, Jia H, Lei M. Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib. Biomolecules 2022;12:1647. [DOI: 10.3390/biom12111647] [Reference Citation Analysis]
|
8 |
Caracciolo D, Juli G, Riillo C, Coricello A, Vasile F, Pollastri S, Rocca R, Scionti F, Polerà N, Grillone K, Arbitrio M, Staropoli N, Caparello B, Britti D, Loprete G, Costa G, Di Martino MT, Alcaro S, Tagliaferri P, Tassone P. Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin. J Transl Med 2022;20:482. [PMID: 36273153 DOI: 10.1186/s12967-022-03705-z] [Reference Citation Analysis]
|
9 |
Yu CC, Li Y, Cheng ZJ, Wang X, Mao W, Zhang YW. Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions. Front Pharmacol 2022;13:818179. [PMID: 35153791 DOI: 10.3389/fphar.2022.818179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
10 |
Liu X, Shen J, Zhu K. Antibacterial activities of plant-derived xanthones. RSC Med Chem . [DOI: 10.1039/d1md00351h] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|